Life ScienceCompany
Nalpropion Pharmaceuticals M&A Summary
Nalpropion Pharmaceuticals has acquired 1 company of its own.
Nalpropion Pharmaceuticals’ largest acquisition to date was in 2018, when it acquired OREXIGEN Therapeutics for $75M. Nalpropion Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Nalpropion Pharmaceuticals Ownership
Who owns Nalpropion Pharmaceuticals?
Nalpropion Pharmaceuticals is owned by Currax Pharmaceuticals. It was acquired on September 27, 2019.
Nalpropion Pharmaceuticals Business Overview
Where is Nalpropion Pharmaceuticals headquartered?
Nalpropion Pharmaceuticals is headquartered in San Diego, California.
What sector is Nalpropion Pharmaceuticals in?
Nalpropion Pharmaceuticals is a life science company.
When was Nalpropion Pharmaceuticals founded?
Nalpropion Pharmaceuticals was founded in 2018.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1